Literature DB >> 22260948

Childhood maltreatment is associated with increased body mass index and increased C-reactive protein levels in first-episode psychosis patients.

N Hepgul1, C M Pariante, S Dipasquale, M DiForti, H Taylor, T R Marques, C Morgan, P Dazzan, R M Murray, V Mondelli.   

Abstract

BACKGROUND: The high incidence of the metabolic syndrome in patients with psychosis is mainly attributed to antipsychotic treatment. However, it is also possible that psychological stress plays a role, inducing a chronic inflammatory process that may predispose to the development of metabolic abnormalities. We investigated the association between childhood maltreatment and inflammatory and metabolic biomarkers in subjects with first-episode psychosis and healthy controls.
METHOD: Body mass index (BMI), weight and waist circumference were measured in 95 first-episode psychosis patients and 97 healthy controls. Inflammatory and metabolic markers were measured in a subsample of 28 patients and 45 controls. In all the subjects we collected information on childhood maltreatment and recent stressors.
RESULTS: Patients with childhood maltreatment had higher BMI [25.0 (S.E.=0.6) kg/m2] and C-reactive protein (CRP) levels [1.1 (S.E.=0.6) mg/dl] when compared with healthy controls [23.4 (S.E.=0.4) kg/m2, p=0.030 and 0.2 (S.E.=0.1) mg/dl, p=0.009, respectively]. In contrast, patients without childhood maltreatment were not significantly different from healthy controls for either BMI [24.7 (S.E.=0.6) kg/m2, p=0.07] or CRP levels [0.5 (S.E.=0.2) mg/dl, p=0.25]. After controlling for the effect of BMI, the difference in CRP levels across the three groups remained significant (F 2,58=3.6, p=0.035), suggesting that the increase in inflammation was not driven by an increase in adipose tissue.
CONCLUSIONS: Childhood maltreatment is associated with higher BMI, and increased CRP levels, in patients with a first-episode psychosis. Further studies need to confirm the mechanisms underlying the putative causal relationship between childhood maltreatment and higher BMI, and whether this is indeed mediated by increased inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22260948      PMCID: PMC4081598          DOI: 10.1017/S0033291711002947

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  39 in total

1.  Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis.

Authors:  M Aas; P Dazzan; V Mondelli; T Toulopoulou; A Reichenberg; M Di Forti; H L Fisher; R Handley; N Hepgul; T Marques; A Miorelli; H Taylor; M Russo; B Wiffen; A Papadopoulos; K J Aitchison; C Morgan; R M Murray; C M Pariante
Journal:  Psychol Med       Date:  2010-06-09       Impact factor: 7.723

Review 2.  Chronic stress and comfort foods: self-medication and abdominal obesity.

Authors:  Mary F Dallman; Norman C Pecoraro; Susanne E la Fleur
Journal:  Brain Behav Immun       Date:  2005-07       Impact factor: 7.217

Review 3.  Ancestry as a determinant of mean population C-reactive protein values: implications for cardiovascular risk prediction.

Authors:  Tina Shah; Paul Newcombe; Liam Smeeth; Juliet Addo; Juan P Casas; John Whittaker; Michelle A Miller; Lorna Tinworth; Steve Jeffery; Pasquale Strazzullo; Francesco P Cappuccio; Aroon D Hingorani
Journal:  Circ Cardiovasc Genet       Date:  2010-09-28

4.  The childhood experience of care and abuse questionnaire (CECA.Q): validation in a community series.

Authors:  A Bifulco; O Bernazzani; P M Moran; C Jacobs
Journal:  Br J Clin Psychol       Date:  2005-11

5.  Abuse in childhood and adolescence as a predictor of type 2 diabetes in adult women.

Authors:  Janet W Rich-Edwards; Donna Spiegelman; Eileen N Lividoti Hibert; Hee-Jin Jun; Tamarra James Todd; Ichiro Kawachi; Rosalind J Wright
Journal:  Am J Prev Med       Date:  2010-12       Impact factor: 5.043

6.  Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review.

Authors:  Stéphane Potvin; Emmanuel Stip; Amir A Sepehry; Alain Gendron; Ramatoulaye Bah; Edouard Kouassi
Journal:  Biol Psychiatry       Date:  2007-11-19       Impact factor: 13.382

Review 7.  The inflammatory response is an integral part of the stress response: Implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X.

Authors:  Paul H Black
Journal:  Brain Behav Immun       Date:  2003-10       Impact factor: 7.217

8.  The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia.

Authors:  Martina C M Ryan; Susan Flanagan; Una Kinsella; Frank Keeling; Jogin H Thakore
Journal:  Life Sci       Date:  2004-03-05       Impact factor: 5.037

9.  Interleukin-12 plasma levels in drug-naïve patients with a first episode of psychosis: effects of antipsychotic drugs.

Authors:  Benedicto Crespo-Facorro; Eugenio Carrasco-Marín; Rocío Pérez-Iglesias; José María Pelayo-Terán; Lorena Fernandez-Prieto; Francisco Leyva-Cobián; José Luis Vázquez-Barquero
Journal:  Psychiatry Res       Date:  2008-02-19       Impact factor: 3.222

10.  Gender differences in the association between childhood abuse and psychosis.

Authors:  Helen Fisher; Craig Morgan; Paola Dazzan; Thomas K Craig; Kevin Morgan; Gerard Hutchinson; Peter B Jones; Gillian A Doody; Carmine Pariante; Peter McGuffin; Robin M Murray; Julian Leff; Paul Fearon
Journal:  Br J Psychiatry       Date:  2009-04       Impact factor: 9.319

View more
  26 in total

Review 1.  Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?

Authors:  David Baumeister; Simone Ciufolini; Valeria Mondelli
Journal:  Psychopharmacology (Berl)       Date:  2015-08-14       Impact factor: 4.530

2.  Impulsivity as a moderator of the associations between child maltreatment types and body mass index.

Authors:  Shaquanna Brown; Tarrah B Mitchell; Paula J Fite; Marco Bortolato
Journal:  Child Abuse Negl       Date:  2017-05

3.  Childhood Adversity and Schizophrenia: The Protective Role of Resilience in Mental and Physical Health and Metabolic Markers.

Authors:  Ellen E Lee; Averria Sirkin Martin; Xin Tu; Barton W Palmer; Dilip V Jeste
Journal:  J Clin Psychiatry       Date:  2018 May/Jun       Impact factor: 4.384

4.  C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications.

Authors:  B S Fernandes; J Steiner; H-G Bernstein; S Dodd; J A Pasco; O M Dean; P Nardin; C-A Gonçalves; M Berk
Journal:  Mol Psychiatry       Date:  2015-07-14       Impact factor: 15.992

5.  Patterns of anterior versus posterior white matter fractional anistotropy concordance in adult nonhuman primates: Effects of early life stress.

Authors:  Jeremy D Coplan; Venu Kolavennu; Chadi G Abdallah; Sanjay J Mathew; Tarique D Perera; Gustavo Pantol; David Carpenter; Cheuk Tang
Journal:  J Affect Disord       Date:  2015-12-09       Impact factor: 4.839

Review 6.  Childhood maltreatment and obesity: systematic review and meta-analysis.

Authors:  A Danese; M Tan
Journal:  Mol Psychiatry       Date:  2013-05-21       Impact factor: 15.992

Review 7.  Social Stress and Psychosis Risk: Common Neurochemical Substrates?

Authors:  Romina Mizrahi
Journal:  Neuropsychopharmacology       Date:  2015-09-09       Impact factor: 7.853

Review 8.  From early adversities to immune activation in psychiatric disorders: the role of the sympathetic nervous system.

Authors:  V Mondelli; A C Vernon
Journal:  Clin Exp Immunol       Date:  2019-09       Impact factor: 5.732

9.  Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α.

Authors:  D Baumeister; R Akhtar; S Ciufolini; C M Pariante; V Mondelli
Journal:  Mol Psychiatry       Date:  2015-06-02       Impact factor: 15.992

10.  Haloperidol and olanzapine mediate metabolic abnormalities through different molecular pathways.

Authors:  V Mondelli; C Anacker; A C Vernon; A Cattaneo; S Natesan; M Modo; P Dazzan; S Kapur; C M Pariante
Journal:  Transl Psychiatry       Date:  2013-01-15       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.